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Abstract
Background: Transport of methylmercury (MeHg) across the blood-brain barrier towards the brain side is well
discussed in literature, while ethylmercury (EtHg) and inorganic mercury are not adequately characterized regarding
their entry into the brain. Studies investigating a possible efflux out of the brain are not described to our knowledge.
Methods: This study compares, for the first time, effects of organic methylmercury chloride (MeHgCl), EtHg-containing
thiomersal and inorganic Hg chloride (HgCl2) on as well as their transfer across a primary porcine in vitro model of the
blood-brain barrier.
Results: With respect to the barrier integrity, the barrier model exhibited a much higher sensitivity towards HgCl2
following basolateral incubation (brain-facing side) as compared to apical application (blood-facing side). These HgCl2
induced effects on the barrier integrity after brain side incubation are comparable to that of the organic species,
although MeHgCl and thiomersal exerted much higher cytotoxic effects in the barrier building cells. Hg transfer rates
following exposure to organic species in both directions argue for diffusion as transfer mechanism. Inorganic Hg
application surprisingly resulted in a Hg transfer out of the brain-facing compartment.
Conclusions: In case of MeHgCl and thiomersal incubation, mercury crossed the barrier in both directions, with a
slight accumulation in the basolateral, brain-facing compartment, after simultaneous incubation in both compartments.
For HgCl2, our data provide first evidence that the blood-brain barrier transfers mercury out of the brain.
Keywords: Organic mercury, Inorganic mercury, Methylmercury, Thiomersal, Mercuric mercury, In vitro blood-brain
barrier model
Background
Mercury (Hg) is present in the environment due to both
natural sources and anthropogenic activity. It exists as
elemental Hg as well as inorganic and organic compounds,
all incorporating different toxicological properties [1, 2].
Human exposure to organic species mainly results from the
consumption of contaminated fish or seafood in the form
of methylmercury (MeHg), the most frequently occurring
organic species in the aquatic food chain [3]. The use of the
ethylmercury (EtHg) containing preservative thiomersal in
medical preparations, including vaccines, represents a non-
dietary route of human exposure towards organic Hg spe-
cies [4]. In contaminated terrestrial food, Hg is mainly
present as inorganic Hg [2]. In 2012, in accordance to the
Joint FAO/WHO Expert Committee on Food Additives
(JECFA) [2] the European Food Safety Authority (EFSA)
Panel on Contaminants in the Food Chain established a tol-
erable weekly intake (TWI) of 4 μg/kg body weight (b.w.)
for inorganic Hg [5]. Based on new epidemiological data,
the EFSA Panel reevaluated for MeHg the provisional toler-
able weekly intake (PTWI) of 1.6 μg/kg b.w. (JECFA [6])
and established a TWI of 1.3 μg/kg b.w.. High fish con-
sumers may exceed this TWI by up to six fold [5].
The central nervous system (CNS) represents the major
target organ of organic Hg species exposure [7]. Thiomersal
shows a higher or at least similar toxicity compared to
MeHg in brain associated cells in vitro (e.g. [8, 9]). How-
ever, the toxic potential of MeHg under in vivo conditions
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seems to be higher, which might be a consequence of differ-
ent disposition kinetics [10].
The transport of MeHg across the blood-brain barrier to
the brain side is well described in literature, while EtHg and
inorganic Hg are not adequately characterized regarding
their entry into the brain. Based on in vitro as well as in
vivo studies an active transport mechanism of MeHg as a
cysteine complex (MeHg-S-Cys) across the blood-brain
barrier via the L-type neutral amino acid transport (LAT)
system has been proposed [11–14]. It has to be noted that
the transport of MeHg across the blood-brain barrier in-
volves both, uptake into and efflux from brain endothelial
cells. Heggland et al. postulated that LAT does not seem to
be involved in the efflux of MeHg in vitro but that MeHg is
transferred out of brain endothelial cells as a complex with
glutathione (GSH), thereby using GSH-transporters [15]. In
2013 Zimmermann et al. postulated a LAT system based
uptake of MeHg-S-Cys as well as EtHg-S-Cys into C6 gli-
oma cells, whereas MeHg and EtHg enter the cells by other
mechanisms [16]. Besides this active, energy dependent
transfer of organic Hg species, transfer mechanisms can be
passive depending on the Hg species [17]. Following intra-
muscular injection of 20 μg thiomersal in mice, EtHg as
well as inorganic Hg were identified in brain tissue indicat-
ing that EtHg can pass the blood-brain barrier [18]. In vivo,
a rapid metabolism of EtHg to inorganic Hg is described
[10, 19]. Thus, because of a possible dealkylation of the or-
ganic compounds as well as an oxidation of elemental Hg,
e.g. resulting from the outgassing of amalgam fillings, inor-
ganic Hg has to be taken into account, when investigating
mechanisms of Hg species dependent transfer into/out of
the brain and Hg species induced neurotoxicity [20, 21].
Toimela et al. demonstrated transfer differences between
mercury chloride (HgCl2) and methylmercury chloride
(MeHgCl) within an in vitro blood-brain barrier model
composed of rat brain endothelial cells accompanied with
glia cells and neuronal SH-SY5Y cells as target cells [22].
The authors concluded from cytotoxic effects on the neur-
onal cells in the brain-facing compartment that MeHgCl
passed the barrier model because it exerted cytotoxic ef-
fects on the neuronal cells, while barrier-building cells were
not affected. HgCl2 did not cause any toxicity to neuronal
cells, as long the barrier cells were not affected [22].
In the present study, a well-characterized primary porcine
in vitro blood-brain barrier model was applied to compare
the effects of MeHgCl, thiomersal and HgCl2 on the barrier
as well as to characterize their transfer properties across this
barrier model. In contrast to existing studies, we focused on
both transfer into as well as transfer out of the brain.
Methods
Primary blood-brain barrier cell culture model
Isolation, cultivation and cryopreservation of primary por-
cine brain capillary endothelial cells (PBCECs) from brain
tissue of freshly slaughtered pigs (from the slaughterhouse)
was performed as previously described [23, 24]. On day in
vitro (DIV) 2, PBCECs were thawed and seeded on rat tail
collagen-coated Transwell® filter inserts with microporous
polycarbonate membranes (1.12 cm2 growth area, 0.4 μM
pore size; Corning, Wiesbaden, Germany) in plating
medium (Medium 199 Earle supplemented with 10% new-
born calf serum, 0.7 μM L-glutamine, 100 μg/mL gentamy-
cin, 100 U/mL penicillin, 100 μg/mL streptomycin (all
Biochrom, Berlin, Germany)) according to literature [25].
After 2 days of proliferation (DIV 2–4) PBCECs reached
confluence and differentiation was induced by replacing the
plating medium with serum-free culture medium (Dulbec-
co’s modified Eagle’s medium/Ham’s F12 (1:1) with 4.1 mM
L-glutamine, 100 μg/mL gentamycin, 100 U/mL penicillin,
100 μg/mL streptomycin (Biochrom) and 550 nM hydro-
cortisone (Sigma Aldrich, Deisenhofen, Germany)) [26].
According to manufacturer’s information, this medium
contains 15.75 mg/L (100 μM) L-cysteine*HCl and 17.24
mg/L (115 μM) L-methionine. All experiments were started
after another 2 days of differentiation (DIV 6). The PBCECs
built up a tight monolayer on the rat tail collagen-coated
polycarbonate membranes comparable to the epithelium of
a brain microvessel. The collagen coating on the filter cor-
responds to the basal membrane in vivo. Epithelial cells
seeded on this surface in vitro develop tight junctions en-
suring the polarity between apical and basolateral cell
membranes. Thus, in this fully developed in vitro model of
the blood-brain barrier the apical (upper) compartment re-
fers to the lumen of the vessel in vivo and therefore mimics
the blood side. Vice versa, the basolateral compartment
represents the parenchymal side of the blood-brain barrier
and mimics the brain side in vivo [23].
Preparation of Hg species stock solutions
Stock solutions of MeHgCl (>99.9% purity, Sigma
Aldrich, Deisenhofen, Germany), thiomersal (>97% pur-
ity, Sigma Aldrich) and HgCl2 (>99.999% purity, Sigma
Aldrich) were prepared in sterile distilled water shortly
before each experiment. Thiomersal is well known to re-
lease ethylmercury (EtHg) in aqueous solutions [27].
Cytotoxicity testing
For the evaluation of cytotoxic effects of the Hg species on
PBCECs the neutral red uptake assay was performed to
quantify the lysosomal integrity. This endpoint has been
shown before to be both applicable to assess viability of
compounds in PBCECs in general [25] and to be suitable to
assess cytotoxicity of mercury species e.g. in human astro-
cytes [8]. The cellular uptake of neutral red depends on the
cell’s capacity to maintain pH gradients, which strongly de-
pends on the cellular ATP level [28]. Fonfria et al. demon-
strated both, decreased intracellular ATP levels as well as
decreased mitochondrial activity, in murine cerebellar
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granule cells following incubation of high MeHgCl and
HgCl2 concentrations [29], providing additional evidence
that lysosomal integrity is a suitable marker to assess Hg
species induced cytotoxicity. Briefly, PBCECs were culti-
vated in rat tail collagen-coated 96 well culture plates under
the same conditions as the cells seeded on Transwell® filter
inserts. Cells were exposed to the respective Hg species on
DIV 6. After 72 h the neutral red uptake assay was carried
out according to literature [25].
Cellular bioavailability
PBCECs were cultivated in rat tail collagen-coated 24 well
culture plates and cultured according to the cultivation in
Transwell® filters. After 72 h incubation of the respective
Hg species, PBCECs were washed twice with PBS (100
mM NaCl, 4.5 mM KCl, 7 mM Na2HPO4, 3 mM KH2PO4
(all Sigma Aldrich); pH 7.4) and incubated with 120 μL
lysis buffer (RIPA-buffer; 0.01 M Tris, pH 7.6, 0.15 M
NaCl, 0.001 M EDTA, 1% sodium desoxycholate, 0.1% (all
Sigma Aldrich)) for 15 min on ice. After scrapping off and
sonication, the suspension of lysed cells was centrifuged at
10 000 x g for 20 min at 4 °C. Total cellular Hg content
was quantified by inductively coupled mass spectrometry
(ICP-MS; Agilent 8800 ICP-QQQ, Agilent Technologies
Deutschland GmbH, Boeblingen, Germany) in an aliquot
of the supernatant. The Bradford assay was used to deter-
mine the cellular protein level.
Barrier integrity, capacitance and transfer measurements
The organic (0.01–3 μM) and the inorganic (0.01–100
μM) Hg species were applied on DIV 6 either to the apical
(blood-facing) or to the basolateral (brain-facing) com-
partment of the in vitro blood-brain barrier model or to
both compartments simultaneously by replacing 10% of
the culture medium with fresh Hg species containing
medium in the respective compartment. Barrier integrity
was monitored during 72 h of incubation by measurement
of the transendothelial electrical resistance (TEER) using
the cellZscope (nanoAnalytics, Münster, Germany). Fur-
thermore, the capacitance, which is related to the plasma
membrane surface area, was recorded online (cellZscope;
nanoAnalytics, Münster, Germany). Wells with TEER
values of ≥ 600 Ω x cm2 and a capacitance of 0.45–0.6 μF/
cm2 were used for the experiments providing a confluent
PBCEC monolayer with tight barrier properties. Standard
deviation of TEER values was < 18% and for capacitance
values < 11% (not shown).
For transfer studies aliquots of both compartments
were taken after 0, 3, 6, 24, 48 and 72 h in case of incu-
bation on one side. In case of application on both sides
simultaneously the first sample was collected after 1.5 h.
The total Hg amount in these samples was quantified by
ICP-MS. Hg transfer was calculated as % in relation to
the total Hg content in both compartments.
ICP-MS analysis
For quantification of the total Hg content by ICP-MS,
aliquots of the transfer studies and cellular bioavailability
studies were diluted in a solution of 5% HNO3 + 5% HCl
(v/v, both suprapur, Merck KGaA). An external calibra-
tion (1–150 ng/L; Hg standard for ICP, TraceCERT®,
Fluka, Deisenhofen, Germany) was prepared in the same
solution. Samples and calibration standards were incu-
bated with rhodium (final concentration 10 ng/L; Merck
KGaA, Darmstadt, Germany) as internal standard. A
MicroMist nebulizer was used for sample introduction
and gas flows were applied as follows: 15 L/min cool
gas, 0.9 L/min auxiliary gas and 1 L/min nebulizer gas.
The method exhibits a limit of detection of 0.8 ng/L and
a limit of quantification of 2.9 ng/L calculated by the
calibration method of the German Standard DIN stand-
ard 32645 [30].
Results
Cytotoxicity and bioavailability in primary PBCECs
Cell viability was assessed in confluent PBCECs by lyso-
somal integrity. The organic Hg species MeHgCl (EC70
1.5 μM) and thiomersal (EC70 1.2 μM) exerted higher
cytotoxic effects as compared to inorganic HgCl2 (EC70 80
μM), with thiomersal being the most cytotoxic compound
(Fig. 1a – c). In accordance to the higher cytotoxicity of
the respective organic species, PBCECs showed higher
intracellular total Hg concentrations following exposure
to subcytotoxic but transfer relevant concentrations (0.01,
0.1 and 1 μM) of the organic mercury species (Table 1).
Evaluation of the barrier integrity and the capacitance
The applied well-characterized cell culture model of the
blood-brain barrier is built up by fully differentiated
PBCECs cultivated on Transwell® filter inserts between
two fluid compartments filled with cell culture medium
[23, 24]. The upper apical compartment refers to the
blood side in vivo, whereas the lower basolateral com-
partment represents the brain side. The impact of the
mercury species on the barrier integrity was assessed by
online monitoring of the transendothelial electrical re-
sistance (TEER) during the entire transfer experiment,
since the electrical resistance correlates with the tight-
ness of the barrier.
Comparing the apical and the basolateral application a
higher sensitivity of the barrier to all species following brain
side incubation was observable (Fig. 2a – f). The barrier in-
tegrity was massively disturbed below TEER values of 30%
of the start value, leaving a weakened barrier with 10–300
Ω xcm2 (depending on the start value). Following incuba-
tion on the apical side (blood-facing side), 3 μM MeHgCl
or thiomersal, and 100 μMHgCl2 disrupted the tightness of
the barrier (Fig. 2a – c). In case of 2 μM thiomersal as well
as 1 and 10 μM HgCl2 incubation, early barrier disturbing
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effects were also visible. Nevertheless, the TEER values in-
creased again at later time points, indicating a recovery of
the barrier functions.
After basolateral incubation (brain-facing side) the
barrier integrity is irreversibly affected at 3 μM MeHgCl,
1 μM thiomersal and 1 μM HgCl2 (Fig. 2d – f ). 1 and 2
μM MeHgCl strongly decreased TEER values to 15–35%
but allowed a reconstitution of the barrier integrity to
about 70%.
Since the electrical capacitance is related to the plasma
membrane surface area, online monitoring of the electrical
capacitance within the in vitro model of the blood-brain
barrier indicates cytotoxic effects (Fig. 3a – f). The apical
and the basolateral incubation of 3 μM MeHgCl lead to a
strong increase of the electrical capacitance, pointing to-
wards an enlarged cell volume, apoptotic or detached cells.
Following apical incubation of thiomersal the electrical cap-
acitance started to increase at a concentration of 2 μM,
whereas the application of 1 μM on the basolateral side of
the endothelial cells increased the capacitance dramatically.
A concentration of 100 μM HgCl2 caused no effect on the
capacitance after apical application, but an increase of
capacitance following basolateral incubation.
Transfer across the in vitro model of the blood-brain
barrier
Transfer across the blood-brain barrier was assessed at
0.01, 0.1 and 1 μM of the Hg species. The barrier tight-
ness was not affected by these concentrations, except for
a basolateral incubation with 1 μM thiomersal or HgCl2.
The application of MeHgCl in the apical compartment
led to similar Hg transfer rates for all concentrations
(Fig. 4a – c). Within the first 6 h, the Hg content increased
to 50–60% of the total applied mercury in the basolateral
compartment and reached a maximum of 75% in the fol-
lowing 66 h. The Hg amount on the apical side decreased
correspondingly. After incubation in the basolateral com-
partment, the application of 0.01 μM MeHgCl led to a
rapid transfer towards the blood side, reaching 60% of the
applied Hg amount in this compartment. In case of 0.1
and 1 μM MeHgCl application, Hg was slowly transferred
out of the basolateral compartment. Nevertheless, the total
Fig. 1 Cytotoxicity of MeHgCl (a), thiomersal (b) and HgCl2 (c) in
PBCECs after 72 h incubation. Cytotoxicity was determined by a
decrease of the lysosomal integrity measured by neutral red uptake.
PBCECs were cultivated in rat tail collagen-coated 96 well culture
plates under the same conditions as the cells seeded on Transwell®
filter inserts. Shown are mean values of at least 3 independent
determinations with 6 replicates + SD
Table 1 Cellular bioavailability of MeHgCl, thiomersal and HgCl2






MeHgCl 0.01 0.010 ± 0.004
0.1 0.135 ± 0.051
1 0.807 ± 0.059
thiomersal 0.01 0.021 ± 0.002
0.1 0.084 ± 0.023
1 0.511 ± 0.107
HgCl2 0.01 0.004 ± 0.000
0.1 0.010 ± 0.002
1 0.047 ± 0.033
PBCECs were cultivated in rat tail collagen-coated 24 well culture plates under the
same conditions as the cells seeded on Transwell® filter inserts. Data represent mean
values of at least 2 independent determinations with 2 replicates each ± SD
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Hg content on the apical side of the endothelial cells did
not exceed the Hg amount in the brain side (Fig. 4d – f).
The apical incubation of 0.01 μM thiomersal resulted in
an equalization of the Hg content in both compartments
(Fig. 5a). The Hg transfer behavior from the apical to the
basolateral side following incubation with 0.1 and 1 μM
thiomersal was comparable to the Hg transfer following
MeHgCl exposure (Fig. 5b, c). In case of basolateral incu-
bation with 0.01 and 0.1 μM thiomersal, the Hg contents
in both compartments converge. The disturbance of the
barrier integrity at 1 μM led to equally distributed Hg con-
tents in both compartments (Fig. 5d – f ).
The transfer following inorganic HgCl2 exposure clearly
differs from the organic mercury species. Thus, after 72 h
of exposure in the apical compartment nearly the whole Hg
amount was still present in this compartment (Fig. 6a – c).
In contrast, application on the basolateral side led to Hg
transfer rates of up to 30% towards the acceptor compart-
ment (Fig. 6d, e). The concentration exchange following 1
μM HgCl2 incubation reflected the affected tightness and
leakage of the barrier (Fig. 6f).
In a further approach, each 0.1 μM MeHgCl, thiomersal
and HgCl2 were applied on both sides simultaneously
(Fig. 7a – c). The slight Hg accumulation in the basolateral
compartment within the first 48 h and the Hg concentra-
tion balancing after 72 h of exposure to MeHgCl and thio-
mersal do not indicate an active transfer mechanism from
the apical to the basolateral side of the endothelial cells. In
case of simultaneous HgCl2 application in both compart-
ments, Hg accumulated in the apical compartment.
Discussion
The primary target organ of organic Hg species mediated
toxicity is the CNS [31]. In literature, the understanding of
Fig. 2 Effect of MeHgCl, thiomersal and HgCl2 on the barrier integrity of the PBCEC monolayer after application in the basolateral compartment
(blood side, a – c) and in the apical compartment (brain side, d – f) for 72 h. Barrier integrity was determined by online measurement of the TEER.
Shown are mean values, expressed as % of start value, of at least 3 independent determinations with 2 replicates minimum with SD < ± 20%
(not shown)
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transfer mechanisms into the brain is limited to MeHg; first
evidence exists for a comparable carrier mediated transfer
mechanism for EtHg [11, 16]. To our knowledge, a possible
efflux of organic and inorganic mercury species out of the
brain side has yet not been evaluated. Although inorganic
Hg does not seem to be able to cross the blood-brain bar-
rier [32], it is present in the brain due to dealkylation of or-
ganic species or an oxidation of elemental Hg [18, 21].
Thus, the elucidation of an efflux of inorganic Hg besides
the organic compounds is of special interest.
According to previous cytotoxicity studies in a human as-
trocytoma cell line [8], organic MeHgCl and thiomersal
exerted in the present study stronger cytotoxic effects in
the barrier building PBCECs as compared to inorganic
HgCl2. The bioavailability studies, performed in subcyto-
toxic but transfer relevant concentrations, give evidence
that this enhanced cytotoxicity is a result of a higher cellular
Hg content following exposure to the organic compounds.
The TEER measurements clearly demonstrate differ-
ences in barrier integrity following basolateral incubation
(brain side) as compared to apical (blood side) incuba-
tion. Barrier leakage caused by 3 μM of the organic and
100 μM of the inorganic species applied in the apical
compartment correlated with the respective cytotoxic
effects. In contrast, after basolateral application, the bar-
rier was more sensitive towards all mercury species, but
especially to inorganic HgCl2. This enhanced sensitivity
of the barrier integrity towards basolateral HgCl2 appli-
cation is not in line with the results of the cytotoxicity
and bioavailability data, showing more than 10 fold
higher cellular Hg concentrations after exposure to the
organic species than to HgCl2.
Since in literature most studies investigating Hg medi-
ated neurotoxicity focus on MeHg or EtHg, the effects
of inorganic Hg species on brain endothelial cells are
poorly understood. Oppedisano et al. demonstrated a
Fig. 3 Effect of MeHgCl, thiomersal and HgCl2 on the electrical capacitance after application in the apical compartment (blood side, a – c) and in
the basolateral compartment (brain side, d – f) for 72 h. Shown are mean values of at least 3 independent determinations with 2 replicates
minimum with SD < ± 10% (not shown)
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more effective inhibition of the glutamine/amino acid
transporter (ASCT2) [33], a carrier located at the ablum-
inal site of the blood-brain barrier with brain to endo-
thelium orientation, by HgCl2 as compared to MeHgCl
[34]. Fonfria et al. reported an alteration in neuronal glu-
tamate transport associated with the excitatory amino
acid transporter (EAAT3), a transporter with the same
orientation as ASCT2 [33], induced by HgCl2 [29]. It
might be possible, at least because of steric advantage of
the Hg2+ ion as compared to organic Hg species, that
inorganic Hg ions generally exert stronger effects on
transporters located to the abluminal side of the blood-
brain barrier. Thus, a disruption of the barrier tightness
following basolateral incubation might be a consequence
of disturbed transport properties and homeostasis. This
hypothesis needs to be proven in further studies.
Our results indicate a Hg transfer following organic
MeHgCl and thiomersal exposure across the in vitro
model of the blood-brain barrier towards the basolateral
side of the endothelial cells. This is in contrast to
Fig. 4 Transfer of MeHgCl after incubation in the apical compartment (blood side, a – c) and in the basolateral compartment (brain side, d – f)
for 72 h. Data are expressed as % of the whole Hg amount quantified in both compartments. Shown are mean values of at least 3 independent
determinations with 3 replicates ± SD
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inorganic HgCl2, which does not seem to be transferred
towards the basolateral compartment in the case of an
intact barrier. These results correspond to different in
vivo studies, postulating a transfer of organic species
into the brain [10, 18]. Since the respective culture
media in the present study contains cysteine, a complex
formation of organic species with cysteine is conceivable.
These complexes have been shown before to enter the
brain via a neutral amino acid carrier by mimicking the
structure of methionine. Nevertheless, it has also been
taken into account that the medium contains substantial
levels of methionine, which has been discussed to dis-
turb the transport of the respective organic mercury
cysteine complexes [11, 16]. We can also not fully ex-
clude that the applied lipophilic organic Hg species are
not fully complexed to thiols and thus are capable to
transfer across cell barriers by diffusion, whereas the
hydrophilic inorganic HgCl2 is not expected to diffuse
through cell membranes [11, 12]. Since total Hg blood
concentrations of 0.6–30 μg/L (0.03–0.15 μM) are re-
lated to dietary Hg exposure in a population group with
a wide range of seafood consumption and Hg is mainly
Fig. 5 Transfer of thiomersal after incubation in the apical compartment (blood side, a – c) and in the basolateral compartment (brain side, d – f)
for 72 h. Data are expressed as % of the whole Hg amount quantified in both compartments. Shown are mean values of at least 3 independent
determinations with 3 replicates ± SD
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present as MeHg in marine food [35], the application of
0.01 and 0.1 μM represent concentrations of physio-
logical relevance. Burbacher et al. reported total blood
Hg concentrations of 8–18 ng/mL (0.04–0.09 μM) 2
days after oral exposure of 20 μg/kg MeHg as MeHg hy-
droxide in infant monkeys. The intramuscular injection
of one single thiomersal dose in humans (20 μg/kg) led
to total blood Hg concentrations of 6–14 ng/L (0.03–
0.07 μM) [10]. The concentrations of HgCl2 used are of
experimental importance to suggest that Hg2+ appar-
ently tends to transfer more easily from the basolateral
to the apical side of the blood-brain barrier model than
from the apical to the basolateral side.
In a second approach, we investigated for the first time
Hg transfer from the basolateral side to the apical side
of the PBCECs (efflux). After application of the organic
compounds in the basolateral compartment, a Hg trans-
fer out of the brain-facing compartment was evident.
Nevertheless, efflux rates were lower as compared to in-
flux rates. Surprisingly, Hg transfer data after basolateral
HgCl2 incubation indicate for an Hg efflux. These results
are in accordance to the simultaneous application on
Fig. 6 Transfer of HgCl2 after incubation in the apical compartment (blood side, a – c) and in the basolateral compartment (brain side, d – f) for
72 h. Data are expressed as % of the whole Hg amount quantified in both compartments. Shown are mean values of at least 3 independent
determinations with 3 replicates ± SD
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both sides. Whereas the simultaneous application of or-
ganic species led to a slight accumulation on the basolat-
eral side within the first 48 h, the inorganic species
clearly accumulated in the apical compartment. Since a
dealkylation of organic species in the brain, especially
the in vivo observed rapid conversion of EtHg to inor-
ganic Hg [18], as well as the oxidation of elemental Hg
result in the presence of inorganic Hg in the brain, these
findings might indicate a possible detoxification mech-
anism in Hg mediated neurotoxicity. Based on the efflux
of inorganic Hg, the blood-brain barrier might protect
the target organ brain from Hg induced neurotoxic dam-
age. The results of the simultaneous incubation of the
organic compounds argue for diffusion as transfer mech-
anism. According to uptake studies in brain endothelial
cells [15] an active carrier mediated transport to the
brain side as well as to the blood side can be excluded
for MeHgCl and thiomersal.
Conclusions
Applying a well-characterized primary blood-brain barrier
model, mercury influx and efflux were assessed, after ex-
posure towards organic MeHgCl, thiomersal, and inorganic
HgCl2. Our data indicate for the organic mercury species a
transfer in both directions, with a slight accumulation on
the basolateral side of the endothelial cells (brain side),
thereby arguing for diffusion as transfer mechanism. HgCl2
was not able to cross the in vitro barrier towards the baso-
lateral side, but partially transferred out of the basolateral
compartment following basolateral incubation. Thus, the
blood-brain barrier might play a role in preventing the
target organ brain from Hg induced neurotoxic effects.
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